drugset / Trial / NCT03044873

Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin

NCT03044873

Phase 1 Completed 20 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelBasic science

Summary

The study is to assess the effect of coadministration of multiple doses of BMS-986165 on the systemic exposure of rosuvastatin in healthy participants.

Timeline

Start
2017-02-02
Primary completion
2017-03-14
Completion
2017-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule
Subject Rosuvastatin Small molecule Oral